The Technical AnalystExchange: SAU
Ame Company For Medical Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.14% SAR60.90
America/New_York / 25 apr 2024 @ 08:10
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 426.30 mill |
| EPS: | 4.78 |
| P/E: | 12.74 |
| Earnings Date: | Jun 17, 2024 |
| SharesOutstanding: | 7.00 mill |
| Avg Daily Volume: | 0.0156 mill |
| RATING 2024-04-25 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | |||||
|---|---|---|---|---|---|
| 2/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | |||
| Gr.Profit | n/a | n/a | |||
| Ebit | n/a | n/a | |||
| Asset | n/a | n/a | |||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.50x |
| Company: PE 12.74 | sector: PE 25.27 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.38x |
| Company: PE 12.74 | industry: PE 33.61 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SAR98.83 (62.28%) SAR37.93 |
| Date: 2024-04-26 |
| Expected Trading Range (DAY) |
|---|
|
SAR 58.90 - 62.90 ( +/- 3.29%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SAR60.90 (-1.14% ) |
| Volume | 0.0101 mill |
| Avg. Vol. | 0.0156 mill |
| % of Avg. Vol | 64.76 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 9527.SR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
9527.SR
Ame Company For Medical Supplies distributes and markets medical supplies for the aesthetic market in Saudi Arabia. Its products portfolio includes Teoxane, a range of injectable hyaluronic acid-based dermal fillers designed to treat wrinkles on the face and neck; medical laser systems and new therapies; botulinum products; Magellan, an autologous concentration system that delivers concentrated platelets and cells at the point of care; and MINT, an absorbable polydioxanone barbed suture indicated for use in soft tissue approximation. The company was founded in 2005 and is based in Jeddah, Saudi Arabia.